Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Zoetis Inc. announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs.
Do Joint Supplements Actually Work? New Research Review Examines Supplements for Canine Osteoarthritis
If you've practiced veterinary medicine for more than a minute, you've fielded the question: "Should I give my dog glucosamine?" As osteoarthritis remains one of the most common conditions we manage in canine patients, the promise of disease-modifying osteoarthritic drugs (DMOADs) that could actually alter disease progression—not just mask symptoms—is incredibly appealing. But do these supplements live up to their marketing claims?
Investigational anti-cancer DNA therapy eases chronic osteoarthritis pain in dogs—pointing to a new non-opioid path for humans
Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain demonstrating a 90% success rate. In a peer-reviewed studypublished in Frontiers in Veterinary Science(DOI: 10.3389/fvets.2025.1519881), Elenagen reduced osteoarthritis pain scores in companion dogs. Because the same pro-inflammatory cytokine loop drives osteoarthritis and other chronic pain states, the findings offer a promising translational signal for non opioid pain medicine.
Breed-specific evaluation of serum biochemical markers in canine hip dysplasia
A recent study explores the diagnostic potential of serum markers in distinguishing between healthy Tornjak dogs and those with hip dysplasia (CHD). Results reveal significant differences in hyaluronic acid (HA), procollagen II C-terminal propeptide (PIICP), and metalloproteinase 9 (MMP9) levels between the two groups. These findings suggest that serum markers could serve as effective diagnostic tools for CHD in Tornjak dogs, aiding veterinarians in early detection and informed breeding decisions. This breed-specific research contributes valuable insights into managing and mitigating the impact of CHD in dogs.